Drug therapy for heart failure in older patients--what do they want? J Geriatr Cardiol 2015; 12: 165-173.Zachariah D, Taylor J, Rowell N, Spooner C, Kalra PR. Drug therapy for heart failure in older patients-what do they want? J Geriatr Cardiol. 2015;12(2):165-73....
Medical therapy for pediatric heart failure is based on a detailed mechanistic understanding of the underlying causes, which are diverse and unlike those e
Ivabradine slows the elevated heart rate that is often seen in HFrEF patients, through inhibition of the Ifchannel in the sinus node [23]. Ivabradine has been shown to exert a modest beneficial effect on prognosis in HFrEF. For instance, in the Systolic Heart Failure Treatment with the IfInhi...
9.The Experimental Study on Xin Shuai He Ji to Cure Congestive Heart Failure;心衰合剂治疗充血性心力衰竭的实验研究 10.The Clinical Analogy of Chronic Heart Failure Treated by Carvedilol;卡维地洛治疗慢性心力衰竭临床分析 11.Clinical Study of Metoprolol in Chronic Heart Failure;美托洛尔治疗慢性心力衰竭临...
PURPOSE: To obtain a therapeutic agent for conjugate heart failure containing a selective inhibitor of a neutral endopeptidase and an angiotensin transforming enzyme inhibitor. CONSTITUTION: This therapeutic agent combinedly contains a compound of formula I R2 is a 1-7C lower alkyl, formula II, etc...
Abstract 11637: Using Dielectric Sensing in Making Discharge Decision for Patients With Heart Failure Introduction:Decompensated heart failure is a leading cause of hospitalization in the United States and is driven by high readmission rates. Despite numero... RD Mclane,AD Stultz,DF Pauly - 《Circula...
Biotech drug for treating heart failure is backed by medical panel.(Knight Ridder Newspapers) 来自 highbeam.com 喜欢 0 阅读量: 21 作者: P Jacobs 收藏 引用 批量引用 报错 分享 全部来源 求助全文 highbeam.com 相似文献Irvine, Calif.-Based Biotech Firm Files for IPO.(Knight Ridder/Tribune ...
The agent is delivered to the environment surrounding the device at a substantially constant rate for a specified period with a reduced dependence on the environmen... GM Zentner - US 被引量: 130发表: 1989年 Potential advantages of torsemide in patients with heart failure: more than just a ...
Strategy of regulating blood pressure in patients with posterior circulation ischemia complicated with heart failure; 后循环梗死急性期合并心力衰竭血压调控策略 3. Cardiovascular action and therapeutic effect of Xinmailong injection for treating heart failure; 心脉隆注射液药理作用和治疗心力衰竭临床研究进展 ...
Despite considerable therapeutic advances, heart failure remains a medical and socioeconomic problem. Thus, there is a compelling need for new drugs that could improve clinical outcomes. In recent years, new potential therapeutic targets that are involved in the pathogenesis of heart failure have been...